LPL Financial
DARE icon

LPL Financial’s Dare Bioscience DARE Stock Holding History

LPL Financial’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26.6K Hold
14,639
– – ﹤0.01% 5849
2025
Q4 		$28.3K Buy
+14,639
New +$29.2K ﹤0.01% 5773

Other funds holding DARE

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

LPL Financial's DARE Position: Q1 2026 in Review

LPL Financial held its Dare Bioscience (DARE) position steady in Q1 2026 at 14,639 shares worth $26.6K. The position accounts for ﹤0.01% of the portfolio, ranked #5849.

LPL Financial first reported a position in DARE in Q4 2025 and has held it in 2 quarters since. The position peaked at $28.3K in Q4 2025. 25 funds tracked by Wall St. Rank hold DARE as of Q1 2026.

  • LPL Financial held 14,639 shares of Dare Bioscience worth $26.6K as of Q1 2026.
  • LPL Financial left its Dare Bioscience share count unchanged in Q1 2026.
  • Dare Bioscience made up ﹤0.01% of LPL Financial's portfolio in Q1 2026, its #5849 holding.
  • LPL Financial first reported a position in Dare Bioscience in Q4 2025 and has held it in 2 quarters since.
  • LPL Financial's Dare Bioscience position peaked at $28.3K in Q4 2025.
  • 25 funds tracked by Wall St. Rank held Dare Bioscience as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.